{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:00:27Z","timestamp":1773799227846,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67769-3","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:34:48Z","timestamp":1766748888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evidence for Interleukin-17C governing interleukin-17A pathogenicity and promoting asthma endotype switching in bronchiectasis"],"prefix":"10.1038","volume":"17","author":[{"given":"Yu-Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hua","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Zhou","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Yue","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Ge","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Wen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Yi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Cun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8039-8973","authenticated-orcid":false,"given":"Jin-Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"67769_CR1","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino, E. et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur. Respir. J. 50, 1700629 (2017).","journal-title":"Eur. Respir. J."},{"key":"67769_CR2","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","volume":"392","author":"PA Flume","year":"2018","unstructured":"Flume, P. A., Chalmers, J. D. & Olivier, K. N. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet 392, 880\u2013890 (2018).","journal-title":"Lancet"},{"key":"67769_CR3","doi-asserted-by":"publisher","first-page":"1800328","DOI":"10.1183\/13993003.00328-2018","volume":"52","author":"E Polverino","year":"2018","unstructured":"Polverino, E. et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur. Respir. J. 52, 1800328 (2018).","journal-title":"Eur. Respir. J."},{"key":"67769_CR4","doi-asserted-by":"publisher","first-page":"2102730","DOI":"10.1183\/13993003.02730-2021","volume":"59","author":"HK Reddel","year":"2021","unstructured":"Reddel, H. K. et al. Global initiative for asthma strategy 2021: executive summary and rationale for key changes. Eur. Respir. J. 59, 2102730 (2021).","journal-title":"Eur. Respir. J."},{"key":"67769_CR5","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1111\/all.15054","volume":"76","author":"I Agache","year":"2021","unstructured":"Agache, I. et al. Advances and highlights in asthma in 2021. Allergy 76, 3390\u20133407 (2021).","journal-title":"Allergy"},{"key":"67769_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1183\/09031936.00002314","volume":"44","author":"A Lind\u00e9n","year":"2014","unstructured":"Lind\u00e9n, A. & Dahl\u00e9n, B. Interleukin-17 cytokine signalling in patients with asthma. Eur. Respir. J. 44, 1319\u20131331 (2014).","journal-title":"Eur. Respir. J."},{"key":"67769_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"JK Kolls","year":"2004","unstructured":"Kolls, J. K. & Lind\u00e9n, A. Interleukin-17 family members and inflammation. Immunity 21, 467\u2013476 (2004).","journal-title":"Immunity"},{"key":"67769_CR8","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1084\/jem.20061401","volume":"203","author":"S Schnyder-Candrian","year":"2006","unstructured":"Schnyder-Candrian, S. et al. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203, 2715\u20132725 (2006).","journal-title":"J. Exp. Med."},{"key":"67769_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1165\/rcmb.2014-0097OC","volume":"52","author":"BP Tian","year":"2015","unstructured":"Tian, B. P. et al. Exogenous interleukin-17A inhibits eosinophil differentiation and alleviates allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 52, 459\u2013470 (2015).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"67769_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","volume":"391","author":"A Papi","year":"2018","unstructured":"Papi, A., Brightling, C., Pedersen, S. E. & Reddel, H. K. Asthma. Lancet 391, 783\u2013800 (2018).","journal-title":"Lancet"},{"key":"67769_CR11","doi-asserted-by":"crossref","unstructured":"Polverino, E. et al. Self-reported Asthma as A Co-morbidity of Bronchiectasis in the EMBARC Registry. (Second World Bronchiectasis Conference, 2017).","DOI":"10.1007\/978-3-319-61452-6_15"},{"key":"67769_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/resp.13026","volume":"22","author":"C Porsbjerg","year":"2017","unstructured":"Porsbjerg, C. & Menzies-Gow, A. Co-morbidities in severe asthma: clinical impact and management. Respirology 22, 651\u2013661 (2017).","journal-title":"Respirology"},{"key":"67769_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.anai.2018.02.016","volume":"120","author":"I Coman","year":"2018","unstructured":"Coman, I. et al. Bronchiectasis in severe asthma: Clinical features and outcomes. Ann. Allergy Asthma Immunol. 120, 409\u2013413 (2018).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"67769_CR14","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1016\/j.jaip.2023.05.041","volume":"11","author":"SA Bendien","year":"2023","unstructured":"Bendien, S. A. et al. Real-world effectiveness of IL-5\/5Ra targeted biologics in severe eosinophilic asthma with comorbid bronchiectasis. J. Allergy Clin. Immunol. Pr. 11, 2724\u20132731.e2722 (2023).","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"67769_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","volume":"7","author":"JD Chalmers","year":"2019","unstructured":"Chalmers, J. D. et al. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respir. Med. 7, 845\u2013854 (2019).","journal-title":"Lancet Respir. Med."},{"key":"67769_CR16","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1183\/13993003.01862-2015","volume":"47","author":"B Mao","year":"2016","unstructured":"Mao, B., Yang, J. W., Lu, H. W. & Xu, J. F. Asthma and bronchiectasis exacerbation. Eur. Respir. J. 47, 1680\u20131686 (2016).","journal-title":"Eur. Respir. J."},{"key":"67769_CR17","doi-asserted-by":"publisher","first-page":"992","DOI":"10.21037\/jtd.2016.03.72","volume":"8","author":"FJ Chen","year":"2016","unstructured":"Chen, F. J., Liao, H., Huang, X. Y. & Xie, C. M. Importance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma. J. Thorac. Dis. 8, 992\u2013999 (2016).","journal-title":"J. Thorac. Dis."},{"key":"67769_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers, J. D. et al. The bronchiectasis severity index. An international derivation and validation study. Am. J. Respir. Crit. Care Med. 189, 576\u2013585 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"67769_CR19","doi-asserted-by":"publisher","first-page":"160187","DOI":"10.1183\/13993003.01873-2016","volume":"49","author":"J Frija-Masson","year":"2017","unstructured":"Frija-Masson, J. et al. Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis. Eur. Respir. J. 49, 160187 (2017).","journal-title":"Eur. Respir. J."},{"key":"67769_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1183\/09031936.00134910","volume":"38","author":"C Martin","year":"2011","unstructured":"Martin, C. et al. Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur. Respir. J. 38, 939\u2013946 (2011).","journal-title":"Eur. Respir. J."},{"key":"67769_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102974","volume":"60","author":"AM Collin","year":"2020","unstructured":"Collin, A. M. et al. Lung immunoglobulin A immunity dysregulation in cystic fibrosis. EBioMedicine 60, 102974 (2020).","journal-title":"EBioMedicine"},{"key":"67769_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jaci.2016.04.038","volume":"139","author":"RY Kim","year":"2017","unstructured":"Kim, R. Y. et al. MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2. J. Allergy Clin. Immunol. 139, 519\u2013532 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67769_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/thoraxjnl-2011-200160","volume":"67","author":"AT Essilfie","year":"2012","unstructured":"Essilfie, A. T. et al. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 67, 588\u2013599 (2012).","journal-title":"Thorax"},{"key":"67769_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","volume":"36","author":"J Qiu","year":"2012","unstructured":"Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92\u2013104 (2012).","journal-title":"Immunity"},{"key":"67769_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ni.3489","volume":"17","author":"CS Klose","year":"2016","unstructured":"Klose, C. S. & Artis, D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765\u2013774 (2016).","journal-title":"Nat. Immunol."},{"key":"67769_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fimmu.2019.00092","volume":"10","author":"A Ardain","year":"2019","unstructured":"Ardain, A., Porterfield, J. Z., Kl\u00f8verpris, H. N. & Leslie, A. Type 3 ILCs in Lung Disease. Front. Immunol. 10, 92 (2019).","journal-title":"Front. Immunol."},{"key":"67769_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2019.02.001","volume":"50","author":"D Yang","year":"2019","unstructured":"Yang, D. et al. Dysregulated lung commensal bacteria drive interleukin-17B production to promote pulmonary fibrosis through their outer membrane vesicles. Immunity 50, 692\u2013706.e697 (2019).","journal-title":"Immunity"},{"key":"67769_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12931-020-01434-9","volume":"21","author":"G Vella","year":"2020","unstructured":"Vella, G. et al. The IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma. Respir. Res. 21, 176 (2020).","journal-title":"Respir. Res."},{"key":"67769_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.immuni.2011.09.010","volume":"35","author":"SH Chang","year":"2011","unstructured":"Chang, S. H. et al. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 35, 611\u2013621 (2011).","journal-title":"Immunity"},{"key":"67769_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.kint.2020.01.015","volume":"97","author":"F Wang","year":"2020","unstructured":"Wang, F. et al. IL-17C has a pathogenic role in kidney ischemia\/reperfusion injury. Kidney Int. 97, 1219\u20131229 (2020).","journal-title":"Kidney Int."},{"key":"67769_CR31","first-page":"51019","volume":"85","author":"M Facchini","year":"2014","unstructured":"Facchini, M., De Fino, I., Riva, C. & Bragonzi, A. Long term chronic Pseudomonas aeruginosa airway infection in mice. J. Vis. Exp. 85, 51019 (2014).","journal-title":"J. Vis. Exp."},{"key":"67769_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1164\/rccm.200812-1943OC","volume":"180","author":"A Bragonzi","year":"2009","unstructured":"Bragonzi, A. et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am. J. Respir. Crit. Care Med. 180, 138\u2013145 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"67769_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/rr41","volume":"2","author":"S Greenfeder","year":"2001","unstructured":"Greenfeder, S., Umland, S. P., Cuss, F. M., Chapman, R. W. & Egan, R. W. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir. Res. 2, 71\u201379 (2001).","journal-title":"Respir. Res."},{"key":"67769_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaci.2017.02.038","volume":"141","author":"K Sugita","year":"2018","unstructured":"Sugita, K. et al. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J. Allergy Clin. Immunol. 141, 300\u2013310.e311 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67769_CR35","doi-asserted-by":"publisher","first-page":"00364","DOI":"10.1183\/23120541.00364-2019","volume":"6","author":"GM Hynes","year":"2020","unstructured":"Hynes, G. M. & Hinks, T. S. C. The role of interleukin-17 in asthma: a protective response? ERJ Open Res. 6, 00364\u201302019 (2020).","journal-title":"ERJ Open Res."},{"key":"67769_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/02770903.2016.1223687","volume":"54","author":"S Zhao","year":"2017","unstructured":"Zhao, S. et al. Lipopolysaccharides promote a shift from Th2-derived airway eosinophilic inflammation to Th17-derived neutrophilic inflammation in an ovalbumin-sensitized murine asthma model. J. Asthma 54, 447\u2013455 (2017).","journal-title":"J. Asthma"},{"key":"67769_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jaci.2005.09.023","volume":"117","author":"D Hartl","year":"2006","unstructured":"Hartl, D. et al. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117, 204\u2013211 (2006).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67769_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.181836","volume":"9","author":"T Rehman","year":"2024","unstructured":"Rehman, T., Pezzulo, A. A., Thurman, A. L., Zemans, R. L. & Welsh, M. J. Epithelial responses to CFTR modulators are improved by inflammatory cytokines and impaired by antiinflammatory drugs. JCI Insight 9, e181836 (2024).","journal-title":"JCI Insight"},{"key":"67769_CR39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1513\/pats.200907-072DP","volume":"6","author":"ST Holgate","year":"2009","unstructured":"Holgate, S. T., Roberts, G., Arshad, H. S., Howarth, P. H. & Davies, D. E. The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc. Am. Thorac. Soc. 6, 655\u2013659 (2009).","journal-title":"Proc. Am. Thorac. Soc."},{"key":"67769_CR40","doi-asserted-by":"crossref","unstructured":"Xiao, C. et al. Defective epithelial barrier function in asthma. J. Allergy Clin. Immunol. 128, 549\u2013556.e541-512 (2011).","DOI":"10.1016\/j.jaci.2011.05.038"},{"key":"67769_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/all.13997","volume":"75","author":"Y Choi","year":"2020","unstructured":"Choi, Y. et al. Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma. Allergy 75, 95\u2013103 (2020).","journal-title":"Allergy"},{"key":"67769_CR42","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1167\/iovs.18-24672","volume":"59","author":"X Cui","year":"2018","unstructured":"Cui, X., Gao, N., Me, R., Xu, J. & Yu, F. X. TSLP Protects Corneas From Pseudomonas aeruginosa Infection by Regulating Dendritic Cells and IL-23-IL-17 Pathway. Invest Ophthalmol. Vis. Sci. 59, 4228\u20134237 (2018).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"67769_CR43","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1681\/ASN.2017090949","volume":"29","author":"S Krohn","year":"2018","unstructured":"Krohn, S. et al. IL-17C\/IL-17 receptor E signaling in CD4(+) T cells promotes T(H)17 cell-driven glomerular inflammation. J. Am. Soc. Nephrol. 29, 1210\u20131222 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67769_CR44","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","volume":"190","author":"A Johnston","year":"2013","unstructured":"Johnston, A. et al. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J. Immunol. 190, 2252\u20132262 (2013).","journal-title":"J. Immunol."},{"key":"67769_CR45","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2015.03.008","volume":"42","author":"JM Reynolds","year":"2015","unstructured":"Reynolds, J. M. et al. Interleukin-17B antagonizes interleukin-25-mediated mucosal inflammation. Immunity 42, 692\u2013703 (2015).","journal-title":"Immunity"},{"key":"67769_CR46","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1111\/all.14526","volume":"75","author":"H Hong","year":"2020","unstructured":"Hong, H., Liao, S., Chen, F., Yang, Q. & Wang, D. Y. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy 75, 2794\u20132804 (2020).","journal-title":"Allergy"},{"key":"67769_CR47","doi-asserted-by":"publisher","first-page":"L751","DOI":"10.1152\/ajplung.90578.2008","volume":"296","author":"PD Vermeer","year":"2009","unstructured":"Vermeer, P. D. et al. MMP9 modulates tight junction integrity and cell viability in human airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 296, L751\u2013L762 (2009).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"67769_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fimmu.2020.00341","volume":"11","author":"JF Nies","year":"2020","unstructured":"Nies, J. F. & Panzer, U. IL-17C\/IL-17RE: emergence of a unique axis in T(H)17 biology. Front. Immunol. 11, 341 (2020).","journal-title":"Front. Immunol."},{"key":"67769_CR49","doi-asserted-by":"publisher","unstructured":"Talbot, J. et al. Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier. Gene Expression Omnibus (GEO) datasets, figshare https:\/\/doi.org\/10.1038\/s41586-020-2039-9 (2020).","DOI":"10.1038\/s41586-020-2039-9"},{"key":"67769_CR50","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jaci.2024.01.027","volume":"153","author":"E Polverino","year":"2024","unstructured":"Polverino, E. et al. Bronchiectasis and asthma: data from the European Bronchiectasis Registry (EMBARC). J. Allergy Clin. Immunol. 153, 1553\u20131562 (2024).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67769_CR51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3423","volume":"20","author":"HY Kim","year":"2014","unstructured":"Kim, H. Y. et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20, 54\u201361 (2014).","journal-title":"Nat. Med."},{"key":"67769_CR52","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jaci.2017.06.037","volume":"141","author":"PP Hekking","year":"2018","unstructured":"Hekking, P. P. et al. Pathway discovery using transcriptomic profiles in adult-onset severe asthma. J. Allergy Clin. Immunol. 141, 1280\u20131290 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67769_CR53","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jaci.2019.03.027","volume":"144","author":"J \u00d6stling","year":"2019","unstructured":"\u00d6stling, J. et al. IL-17-high asthma with features of a psoriasis immunophenotype. J. Allergy Clin. Immunol. 144, 1198\u20131213 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67769_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aao4747","volume":"3","author":"N Krishnamoorthy","year":"2018","unstructured":"Krishnamoorthy, N. et al. Neutrophil cytoplasts induce T(H)17 differentiation and skew inflammation toward neutrophilia in severe asthma. Sci. Immunol. 3, eaao4747 (2018).","journal-title":"Sci. Immunol."},{"key":"67769_CR55","doi-asserted-by":"publisher","first-page":"L1015","DOI":"10.1152\/ajplung.00158.2016","volume":"311","author":"L Wolf","year":"2016","unstructured":"Wolf, L. et al. IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia. Am. J. Physiol. Lung Cell Mol. Physiol. 311, L1015\u2013l1022 (2016).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"67769_CR56","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.3389\/fimmu.2018.02724","volume":"9","author":"H Gong","year":"2018","unstructured":"Gong, H. et al. IL-17C mitigates murine acute graft-vs.-host disease by promoting intestinal barrier functions and Treg differentiation. Front. Immunol. 9, 2724 (2018).","journal-title":"Front. Immunol."},{"key":"67769_CR57","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.4049\/jimmunol.1103014","volume":"189","author":"JM Reynolds","year":"2012","unstructured":"Reynolds, J. M. et al. Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C. J. Immunol. 189, 4226\u20134230 (2012).","journal-title":"J. Immunol."},{"key":"67769_CR58","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nm.2737","volume":"18","author":"BN Lambrecht","year":"2012","unstructured":"Lambrecht, B. N. & Hammad, H. The airway epithelium in asthma. Nat. Med. 18, 684\u2013692 (2012).","journal-title":"Nat. Med."},{"key":"67769_CR59","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.chom.2022.08.005","volume":"30","author":"L Li","year":"2022","unstructured":"Li, L. et al. Neisseria species as pathobionts in bronchiectasis. Cell Host Microbe 30, 1311\u20131327.e1318 (2022).","journal-title":"Cell Host Microbe"},{"key":"67769_CR60","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1111\/all.14959","volume":"76","author":"JF Tuli","year":"2021","unstructured":"Tuli, J. F. et al. Association between mucosal barrier disruption by Pseudomonas aeruginosa exoproteins and asthma in patients with chronic rhinosinusitis. Allergy 76, 3459\u20133469 (2021).","journal-title":"Allergy"},{"key":"67769_CR61","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ni.2617","volume":"14","author":"P Licona-Lim\u00f3n","year":"2013","unstructured":"Licona-Lim\u00f3n, P., Kim, L. K., Palm, N. W. & Flavell, R. A. TH2, allergy and group 2 innate lymphoid cells. Nat. Immunol. 14, 536\u2013542 (2013).","journal-title":"Nat. Immunol."},{"key":"67769_CR62","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","volume":"174","author":"S Ying","year":"2005","unstructured":"Ying, S. et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. 174, 8183\u20138190 (2005).","journal-title":"J. Immunol."},{"key":"67769_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/ACI.0000000000000497","volume":"19","author":"AC Jonckheere","year":"2019","unstructured":"Jonckheere, A. C., Bullens, D. M. A. & Seys, S. F. Innate lymphoid cells in asthma: pathophysiological insights from murine models to human asthma phenotypes. Curr. Opin. Allergy Clin. Immunol. 19, 53\u201360 (2019).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"67769_CR64","doi-asserted-by":"publisher","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","volume":"53","author":"D Singh","year":"2019","unstructured":"Singh, D. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur. Respir. J. 53, 1900164 (2019).","journal-title":"Eur. Respir. J."},{"key":"67769_CR65","first-page":"1","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill, A. T. et al. British Thoracic society guideline for bronchiectasis in adults. Thorax 74, 1\u201369 (2019).","journal-title":"Thorax"},{"key":"67769_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14945-2","volume":"11","author":"Z Zas\u0142ona","year":"2020","unstructured":"Zas\u0142ona, Z. et al. Caspase-11 promotes allergic airway inflammation. Nat. Commun. 11, 1055 (2020).","journal-title":"Nat. Commun."},{"key":"67769_CR67","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1099\/mic.0.2006\/003400-0","volume":"153","author":"S Montanari","year":"2007","unstructured":"Montanari, S. et al. Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis. Microbiol. 153, 1445\u20131454 (2007).","journal-title":"Microbiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67769-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67769-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67769-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:28:57Z","timestamp":1769527737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67769-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67769"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67769-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1026"}}